ISPOR Launches HEOR by Topic Microsite

Published Apr 2, 2024

Real-World Data, Clinical Outcomes, Digital Health, Health Technology Assessment, and Patient-Centered Research Among the Featured Topics

Lawrenceville, NJ, USA—April 2, 2024—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has launched a new microsite that provides HEOR information and resources organized by topical areas of interest—HEOR by Topic.

The field of HEOR focuses on a variety of diverse topical areas. ISPOR’s new HEOR by Topic microsite organizes the Society’s content by these areas and features valuable content from its conferences and summits, leading journal Value in Health, HEOR magazine Value & Outcomes Spotlight, and more. Featured HEOR topics include:

“We are excited to launch ISPOR’s new HEOR by Topic content,” stated ISPOR CEO and Executive Director, Rob Abbott. “This new microsite enhances the accessibility of resources by aggregating and organizing the Society’s content by topical interest.  These essential resources are available to anyone interested in the field of HEOR.”

In addition to the Society’s new HEOR by Topic microsite, additional information and resources can be found on ISPOR’s website, including:

About HEOR | Top 10 HEOR Trends Report | About Real-World Evidence | HEOR News Desk

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×